SCIENTIFIC REPORT 2010 - 2011 - IOV

Main Pubblications
Clinical Oncology 1
Chief
Vittorina Zagonel, MD
Detecting functional impairment in older patients
with cancer: is vulnerable elders survey-13 the right
prescreening tool? An open question.
Pegylated liposomal doxorubicin and gemcitabine in
patients with advanced hepatocellular carcinoma: results
of a phase 2 study.
Primary tumor response to preoperative chemoradiation
with or without oxaliplatin in locally advanced rectal
cancer: pathologic results of the STAR-01 randomized
phase III trial.
Advanced gastric cancer (GC) and cancer of the gastrooesophageal
junction (GEJ): focus on targeted therapies.
Neoplastic meningitis from solid tumors: new diagnostic
and therapeutic approaches.
Vittorina Zagonel worked at the Clinical Oncology Division of the CRO Aviano Cancer Center
(IRCCS) from 1983 to 1999. From 2000 to 2009, she served as Head of the Clinical Oncology
Unit at the Fatebenefratelli Hospital, Rome, where she also acted as Director of the Department
of Oncology for eight years. Since October 2009 she has been serving as Head of the Clinical
Oncology 1 at Istituto Oncologico Veneto (Padua). She was a member of the National Oncologic
Committee 2008-2009 and a member of the Ministry of Health board for palliative care in 2010.
She coordinates the AIOM task force on Continuous Care in Oncology since 2008. She is author
and coauthor of more than 150 articles in indexed journals.
Falci C, Brunello A, Monfardini S. J Clin Oncol. 2010; 28:665-6
Lombardi G, Zustovich F, Farinati F, Cillo U,
Vitale A, Zanus G, Donach M, Farina M, Zovato
S, Pastorelli D.
Aschele C, Cionini L, Lonardi S, Pinto C, Cordio
S, Rosati G, Artale S, Tagliagambe A, Ambrosini
G, Rosetti P, Bonetti A, Negru ME, Tronconi MC,
Luppi G, Silvano G, Corsi DC, Bochicchio AM,
Chiaulon G, Gallo M, Boni L.
Cappetta A, Lonardi S, Pastorelli D, Bergamo F,
Lombardi G, Zagonel V.
Lombardi G, Zustovich F, Farina P, Della Puppa
A, Manara R, Cecchin D, Brunello A, Cappetta A,
Zagonel V.
THE DEPARTMENTS - DEPARTMENT OF CLINICAL ONCOLOGY
34
Cancer. 2011; 117:125-33
J Clin Oncol. 2011; 29:2773-80
Crit Rev Oncol Hematol. 2011; in
press.
Oncologist. 2011; 16:1175-88